22483 Investors following Lupin. Share this News with them.
0
Like this story, share it with millions of investors on M3
Lupin Q1 net profit seen up at Rs 121.4 cr: Religare
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, Lupin's June quarter sales are expected to go up by 16.4% to Rs 1004 crore on YoY basis.
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, Lupin 's June quarter sales are expected to go up by 16.4% to Rs 1004 crore on YoY basis.
The company's net profit is expected to go up by 8.4% to Rs 121.4 crore on YoY basis.